Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Intrauterine Devices Market: By Type, By Age Group, By End User and Region Forecast 2019 - 2030
Intrauterine Devices Market size was valued at US$ 3,476.4 million in 2023 and is poised to grow at a significant CAGR of 4.1% over 2024-2030. An intrauterine contraceptive device (IUD) is a T-shaped, small, birth control device that's put inside the uterus, to prevent pregnancy. These devices are highly effective at a reasonable cost, and safe to use in case of preventing pregnancy. The contraceptive effect of IUDs is due to the confined inflammation that occurs after their insertion. The inflammatory reaction produced inside the uterus produces substances that are toxic to sperm. Intrauterine devices do not affect breastfeeding and consequently can be used instantly after delivery as well and these can also be used after an abortion has recently been performed. The features and benefits of these devices are the primary factors for the growth of the intrauterine contraceptive devices (IUD) market.
Furthermore, the technological advancements that led to effective contraception, with no side effects further propelled the growth of the intrauterine devices market. Additionally, a rise in the rate of unintended pregnancies, such as the percentage of unwanted pregnancies is observed to be the maximum in teens of the age group of less than 18, followed by women in the age group of 20 to 24 years. These unintentional pregnancies are directly contributing to the flow in the demand for contraceptive devices. Furthermore, favorable government initiatives for the prevention of unwanted pregnancies are expected to expand the market size over the forecasted period. Therefore, the market studies observed that it can be anticipated that the worldwide phenomenon of unintended pregnancies will be a foremost driving factor. Over the past few years, it has been studied that a large number of pregnancies are mistimed, unwanted, and unintended.
On account of this, several governments and non-profit organizations are encouraging the usage of IUDs by educating people about total birth control measures and family planning. Furthermore, the repealing of the Affordable Care Act (ACA) in the United States, has encouraged a major section of women to adopt long-term reversible contraception (LARC) options, such as IUDs, due to the lack of abortion rights, and rising co-payment. The market is further enhanced by technological innovations, such as reusable and postpartum IUDs, all of these are anticipated to propel the growth of the market over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
4.1%Largest Market
Asia PacificFastest Growing Market
North America
The market for intrauterine devices is primarily driven by a rise in the number of unplanned & unintended pregnancies, increasing incidences of unsafe abortion. Moreover, a rise in awareness regarding the use of the device further boosted the demand in the intrauterine devices market. On the other hand, the intrauterine devices market is constrained by some side effects associated with the devices. However, the growing inclination toward planned delayed pregnancy in developed countries is anticipated to create lucrative opportunities among key players.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 3,476.4 million |
Market CAGR |
4.1% |
By Type |
|
By Age Group |
|
By End User |
|
Download Free Sample Report
The global intrauterine devices market size was valued at US$ 3,476.4 million in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030.
Key players’ profiles in the intrauterine devices market report are Bayer AG, The Cooper Companies, Inc., Pfizer Inc., HLL Lifecare Limited, OCON Healthcare, SMB Corporation, Egemen International, Meril Life Sciences Pvt. Ltd.
A rise in the prevalence of unintended pregnancies, with supportive government initiatives for rising awareness regarding family planning, and encouraging the usage and adoption of several contraceptive methods.
1. Executive Summary |
2. Global Intrauterine Devices (IUD) Market Introduction |
2.1. Global Intrauterine Devices (IUD) Market Taxonomy |
2.2. Global Intrauterine Devices (IUD) Market Definitions |
2.2.1. By Type |
2.2.2. By Age Group |
2.2.3. By End User |
2.2.4. By Region |
3. Global Intrauterine Devices (IUD) Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Intrauterine Devices (IUD) Market Dynamic Factors - Impact Analysis |
3.6. Global Intrauterine Devices (IUD) Market Competition Landscape |
4. Global Intrauterine Devices (IUD) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Intrauterine Devices (IUD) Market, By Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Nonhormonal: Copper-containing IUD |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Hormonal: Progestogen-releasing IUD |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Intrauterine Devices (IUD) Market, By Age Group, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. 15-24 years |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. 25-34 years |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. 35-44 years |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Above 44 years |
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Intrauterine Devices (IUD) Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. Hospitals |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Community Health Care Centres |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Intrauterine Devices (IUD) Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Intrauterine Devices (IUD) Market - Opportunity Analysis Index, By Type, By Age Group, By End User, and Region, 2024 - 2030 |
9. North America Intrauterine Devices (IUD) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Nonhormonal: Copper-containing IUD |
9.1.2. Hormonal: Progestogen-releasing IUD |
9.2. Age Group Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. 15-24 years |
9.2.2. 25-34 years |
9.2.3. 35-44 years |
9.2.4. Above 44 years |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Hospitals |
9.3.2. Clinics |
9.3.3. Community Health Care Centres |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Intrauterine Devices (IUD) Market - Opportunity Analysis Index, By Type, By Age Group, By End User, and Country, 2024 - 2030 |
9.6. North America Intrauterine Devices (IUD) Market Dynamics Trends |
10. Europe Intrauterine Devices (IUD) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Nonhormonal: Copper-containing IUD |
10.1.2. Hormonal: Progestogen-releasing IUD |
10.2. Age Group Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. 15-24 years |
10.2.2. 25-34 years |
10.2.3. 35-44 years |
10.2.4. Above 44 years |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Hospitals |
10.3.2. Clinics |
10.3.3. Community Health Care Centres |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Russia |
10.4.7. Rest of Europe |
10.5. Europe Intrauterine Devices (IUD) Market - Opportunity Analysis Index, By Type, By Age Group, By End User, and Country, 2024 - 2030 |
10.6. Europe Intrauterine Devices (IUD) Market Dynamics Trends |
11. Asia-Pacific Intrauterine Devices (IUD) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Nonhormonal: Copper-containing IUD |
11.1.2. Hormonal: Progestogen-releasing IUD |
11.2. Age Group Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. 15-24 years |
11.2.2. 25-34 years |
11.2.3. 35-44 years |
11.2.4. Above 44 years |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Hospitals |
11.3.2. Clinics |
11.3.3. Community Health Care Centres |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. China |
11.4.2. India |
11.4.3. Japan |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Intrauterine Devices (IUD) Market - Opportunity Analysis Index, By Type, By Age Group, By End User, and Country, 2024 - 2030 |
11.6. Asia-Pacific Intrauterine Devices (IUD) Market Dynamics Trends |
12. Latin America Intrauterine Devices (IUD) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Nonhormonal: Copper-containing IUD |
12.1.2. Hormonal: Progestogen-releasing IUD |
12.2. Age Group Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. 15-24 years |
12.2.2. 25-34 years |
12.2.3. 35-44 years |
12.2.4. Above 44 years |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Hospitals |
12.3.2. Clinics |
12.3.3. Community Health Care Centres |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Intrauterine Devices (IUD) Market - Opportunity Analysis Index, By Type, By Age Group, By End User, and Country, 2024 - 2030 |
12.6. Latin America Intrauterine Devices (IUD) Market Dynamics Trends |
13. Middle East and Africa Intrauterine Devices (IUD) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Nonhormonal: Copper-containing IUD |
13.1.2. Hormonal: Progestogen-releasing IUD |
13.2. Age Group Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. 15-24 years |
13.2.2. 25-34 years |
13.2.3. 35-44 years |
13.2.4. Above 44 years |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Hospitals |
13.3.2. Clinics |
13.3.3. Community Health Care Centres |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Intrauterine Devices (IUD) Market - Opportunity Analysis Index, By Type, By Age Group, By End User, and Country, 2024 - 2030 |
13.6. MEA Intrauterine Devices (IUD) Market Dynamics Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Bayer AG |
14.2.2. The Cooper Companies, Inc. |
14.2.3. Pfizer Inc. |
14.2.4. HLL Lifecare Limited |
14.2.5. OCON Healthcare |
14.2.6. SMB Corporation |
14.2.7. Egemen International |
14.2.8. Meril Life Sciences Pvt. Ltd. |
14.2.9. Mona Lisa N.V. |
14.2.10. Prosan International B.V. |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Key Market Players